Table 1 Demographic characteristics of study populations in remission
Diagnosis | GPA | MPA | TAK | GCA |
|---|---|---|---|---|
Number of subjects | 123 | 61 | 58 | 68 |
Gender (female, %) | 64 (52%) | 31 (51%) | 53 (91%) | 49 (72%) |
Age at diagnosis, years (median, range) | 47 (10–80) | 59 (17–82) | 30(12–58) | 69 (54–90) |
Disease duration (mean ± SD, years) | 8.2 ± 7.5 | 4.8 ± 5.2 | 10.4 ± 7.2 | 3.4 ± 3.6 |
ESR (mean ± SD, mm/h) | 12.8 ± 10.8 | 18.9 ± 15.3 | 15.2 ± 15.0 | 14.1 ± 13.1 |
CRP (mean ± SD, mg/dl) | 6.7 ± 8.8 | 4.6 ± 5.4 | 6.9 ± 9.1 | 6.3 ± 7.6 |
Creatinine (mean ± SD, mg/dl) | 1.11 ± 0.60 | 1.61 ± 0.96 | 0.82 ± 0.20 | 0.92 ± 0.20 |
Anti-MPO antibodies (%) | 20 (16%) | 54 (89%) | ND | ND |
Anti-PR3 antibodies (%) | 86 (70%) | 8 (13%) | ND | ND |
PGA (mean ± SD) | 0 | 0 | 0 | 0 |